Prescription Drug Addiction

What is prescription drug addiction?

Prescription drug addiction, more precisely called prescription drug use disorder, refers to a problematic pattern of use of medications that were initially prescribed, or that are misused without a prescription, leading to significant impairment or distress. The DSM-5 categorizes prescription drug use disorder according to the drug class involved: Opioid Use Disorder (for opioid painkillers), Sedative, Hypnotic, or Anxiolytic Use Disorder (for benzodiazepines and sleep medications), and Stimulant Use Disorder (for medications like Adderall and Ritalin).

The three prescription drug classes most commonly involved in addiction are opioid analgesics (oxycodone, hydrocodone, morphine, fentanyl, tramadol), benzodiazepines (alprazolam, diazepam, clonazepam, lorazepam), and stimulants (amphetamine salts such as Adderall, methylphenidate such as Ritalin, and lisdexamfetamine such as Vyvanse). Each carries distinct pharmacological mechanisms, dependence risk profiles, and treatment implications.

Prescription drug misuse is defined as taking a medication in a way other than prescribed, taking someone else's prescription, or taking a prescription medication for its subjective psychoactive effects rather than for its medical purpose. Dependence, however, can develop even with strict adherence to a legitimate prescription, particularly with opioids and benzodiazepines taken over extended periods. This is the clinical reality that makes 'following doctor's orders' insufficient protection against developing a use disorder.

In Monmouth County and across New Jersey, prescription drug use disorders, particularly opioid prescriptions, represent a significant driver of the broader opioid and addiction crisis. The pathway from a legitimate prescription to dependence to illicit opioid use is well-documented in this region and nationally.

Opioid prescription drugs: the most common and highest-risk class

Prescription opioids, including oxycodone (OxyContin, Percocet), hydrocodone (Vicodin), morphine, hydromorphone (Dilaudid), and tramadol, are the most commonly misused prescription drug class and the most directly connected to the current overdose crisis. They are prescribed for acute and chronic pain management, and when used as directed for short periods, they serve a legitimate medical purpose.

Physical dependence can develop in a few weeks of daily opioid use. The brain's opioid receptors down-regulate in response to consistent opioid exposure, meaning the person requires the drug to avoid withdrawal rather than for any pain management benefit. Tolerance develops alongside dependence, driving dose escalation. When the prescription ends, the dependence does not.

A portion of people who develop opioid prescription dependence transition to illicit opioids, primarily heroin and illicit fentanyl, when prescriptions become unavailable or unaffordable. This transition from prescription to street drugs is a well-documented and deeply serious clinical pathway that often involves escalating overdose risk, particularly given the current fentanyl-contaminated supply.

Medication-assisted treatment, specifically buprenorphine (Suboxone, Sublocade), methadone, and naltrexone (Vivitrol), is the evidence-based standard of care for opioid use disorder including prescription opioid addiction. MAT reduces overdose deaths, illicit drug use, and improves social functioning. For a full treatment discussion, see our Opioid Addiction page.

Benzodiazepine prescription drugs: the dangerous withdrawal picture

Benzodiazepines, prescribed for anxiety, panic disorder, insomnia, and seizure management, include Xanax (alprazolam), Valium (diazepam), Klonopin (clonazepam), and Ativan (lorazepam). Physical dependence can develop with regular use over four to six weeks, even at therapeutic doses.

Benzodiazepine withdrawal is medically serious. Like alcohol, abrupt cessation after physical dependence has developed can cause seizures and delirium, which can be life-threatening. This makes benzodiazepine dependence a category where self-managed discontinuation is genuinely dangerous and medically supervised taper is the standard of care.

People who develop benzodiazepine dependence from a legitimate prescription often experience rebound anxiety and insomnia that feel worse than the original condition, driving continued use. They may not recognize this as dependence because the medication is prescribed and they are not seeking a 'high'. They are seeking relief from the withdrawal the medication itself has created.

For a full treatment discussion including the tapering process, CBT for anxiety, and non-benzodiazepine alternatives, see our Benzodiazepine Addiction page.

Stimulant prescription drugs: ADHD medications and misuse

Prescription stimulants, including amphetamine salts (Adderall, Adderall XR), methylphenidate (Ritalin, Concerta), and lisdexamfetamine (Vyvanse), are prescribed primarily for ADHD and, in some cases, narcolepsy. When used as prescribed by someone with ADHD, they produce cognitive and functional improvement through their dopaminergic and noradrenergic effects. When misused for cognitive enhancement, weight management, or recreational purposes, they carry significant dependence and cardiovascular risk.

Stimulant use disorder from prescription stimulants is not the same clinical picture as methamphetamine addiction. Prescription stimulants are longer-acting, lower-potency dopaminergic agents compared to methamphetamine, and the route of administration typically used (oral) produces a less intense and slower onset of effect, which reduces addiction potential compared to smoked or injected methamphetamine. However, misuse at high doses, particularly through routes other than prescribed (crushing and insufflating, for example), substantially elevates the addiction risk.

Stimulant misuse is prevalent in adolescent and young adult populations, on college campuses, and in high-performance professional environments where cognitive demands are high and the social and career pressure to perform is significant. The Archangel Centers serves young adults in Monmouth County who present with stimulant use disorder alongside academic pressure, anxiety, and performance-related identity issues.

Treatment for prescription stimulant use disorder is primarily behavioral: CBT, motivational interviewing, and addressing the underlying ADHD, anxiety, or performance pressure that drove the misuse. When ADHD is a legitimate underlying diagnosis, appropriate non-stimulant or monitored stimulant treatment in a therapeutic context may be part of the recovery plan.

Warning signs of prescription drug addiction

Because prescription drug addiction often begins legitimately, many of the warning signs are rationalizable in ways that street drug addiction is not. Recognizing the pattern across time is what matters.

• Taking medication more frequently or at higher doses than prescribed
• Running out of a prescription before the refill date, repeatedly
• Seeking the same medication from more than one prescriber or pharmacy (doctor shopping)
• Feeling unable to function without the medication, beyond the original condition
• Using someone else's prescription
• Obtaining the medication from non-medical sources when the prescription runs out
• Experiencing withdrawal symptoms when doses are missed: anxiety, insomnia, muscle aches, sweating, nausea depending on the drug class
• Continuing to use the medication despite clear negative consequences to health, relationships, or work
• Defensive or secretive behavior when asked about medication use
• Escalating doses with the belief that 'it's prescribed, so it's safe'

The clinical complexity: when a legitimate condition coexists with addiction

One of the most clinically complex aspects of prescription drug addiction is that the underlying condition that drove the original prescription, pain, anxiety, ADHD, insomnia, often still exists and still needs to be addressed. Recovery from prescription drug dependence does not automatically mean that the original condition resolves.

Managing this complexity requires careful clinical assessment and a treatment plan that addresses both the substance use disorder and the underlying condition, using approaches that do not risk re-creating the dependence. For opioid dependence from chronic pain, this may mean MAT, pain rehabilitation, and non-opioid pain management strategies. For benzodiazepine dependence from anxiety, this means CBT for anxiety and non-benzodiazepine pharmacological options. For stimulant misuse with underlying ADHD, this means a thoughtful evaluation of ADHD treatment that accounts for the misuse history.

This is not simple. It requires a clinical team that understands both addiction treatment and co-occurring mental health and medical conditions. At Archangel, dual-diagnosis assessment and integrated care planning are standard.

Prescription drug addiction treatment at The Archangel Centers

The Archangel Centers provides licensed outpatient addiction treatment for prescription drug use disorders at 44 Apple St STE 3, Tinton Falls, NJ. We serve Monmouth County and the Jersey Shore, with clients from Red Bank, Asbury Park, Long Branch, Neptune, Freehold, Eatontown, and surrounding communities.

Treatment approach depends on the drug class:

For opioid prescription drugs: MAT with buprenorphine (Suboxone, Sublocade) or naltrexone (Vivitrol), combined with structured group and individual therapy in PHP or IOP, is the evidence-based standard. Medical detox coordination before outpatient entry when needed.

For benzodiazepine prescriptions: Medical taper coordination is the essential first step before outpatient behavioral treatment. Following the taper, CBT for anxiety, mindfulness-based approaches, and integrated mental health care address the underlying condition without recreating dependence.

For stimulant prescriptions: Primarily behavioral. CBT, motivational interviewing, and addressing the ADHD, anxiety, or performance-related drivers of misuse. ADHD treatment planning in recovery is coordinated with prescribers within our network.

All levels of care, PHP, IOP, and standard outpatient, are available. Most major insurance plans and New Jersey Medicaid cover these services. Benefits are verified before admission.

Recovery from prescription drug addiction

Recovery from prescription drug addiction is common and well-documented. The clinical picture in early recovery depends on the drug class: opioid recovery involves managing protracted withdrawal and rebuilding reward system function; benzodiazepine recovery involves navigating the slow normalization of GABA receptor function; stimulant recovery involves rebuilding natural reward sensitivity.

Across all three classes, what supports recovery is consistent: a therapeutic relationship with a skilled clinician, community with others who understand the experience, evidence-based skill building for managing the original condition without the drug, and for opioids, medication management with MAT.

People who find recovery from prescription drug addiction often describe a particular experience of feeling seen and not judged. The stigma around prescription drug use disorder, the 'it's just a pill' minimization and the 'you should have known better' judgment, is real and damaging. Our clinical team works with people in exactly this situation and holds the medical frame: this is a condition that developed through the intersection of a prescribed medication, individual neurobiology, and circumstances. It is treatable. You did not fail.

If prescription drug use has become a problem in your life or the life of someone you love in Monmouth County or along the Shore, our admissions team is available around the clock.